Science Explorer Back to mapMap
Discussion
Researcher · Munich Leukemia Laboratory (Germany) · Germany

Claudia Haferlach

Claudia Haferlach publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research and Chronic Myeloid Leukemia Treatments.

ORCID 0000-0002-6333-5049 OpenAlex
World rank
#381,799
of 7,710,434 ranked researchers
Rank in Germany
#18,850
of 364,343
Works
1,335
Citations
32k
Citations per work
23.9
h-index
85
i10-index 327Top 0.6% in Hematology
Claudia Haferlach

What does Claudia Haferlach research?

Claudia Haferlach's work is mostly in Medicine (52%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (4%).

Health Sciences: 701 works · 52.5% of their workMedicine: 701 works · 52.5% of their workHematology: 378 works · 28.3% of their workGenetics: 210 works · 15.7% of their workPathology and Forensic Medicine: 59 works · 4.4% of their workPublic Health, Environmental and Occupational Health: 55 works · 4.1% of their workEverything else: 430 works · 32.2% of their workLife Sciences: 204 works · 15.3% of their workBiochemistry, Genetics and Molecular Biology: 152 works · 11.4% of their workMolecular Biology: 152 works · 11.4% of their workImmunology and Microbiology: 52 works · 3.9% of their workImmunology: 52 works · 3.9% of their workTHEIR WORKClaudia Haferlach1,335works
Life Sciences15%Health Sciences52%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine70152.5%
  2. Everything else43032.2%
    1. Biochemistry, Genetics and Molecular Biology15211.4%
    2. Immunology and Microbiology523.9%
  1. 1Hematology28% of their works
  2. 2Genetics16% of their works
  3. 3Molecular Biology11% of their works
  4. 4Pathology and Forensic Medicine4% of their works
  5. 5Public Health, Environmental and Occupational Health4% of their works
  6. 6Immunology4% of their works

Research topics

Which keywords describe Claudia Haferlach's research?

The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, BCR-ABL and Imatinib.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Prognostic Factors9553 topics
  2. AML5791 topic
  3. Acute Myeloid Leukemia5791 topic
  4. Rituximab3692 topics
  5. Chronic Lymphocytic Leukemia2521 topic
  6. Genomic Aberrations2521 topic
  7. BCR-ABL2361 topic
  8. Imatinib2361 topic
  9. JAK2 Mutation2211 topic
  10. Myelofibrosis2211 topic
  11. Minimal Residual Disease1942 topics
  12. Acute Lymphoblastic Leukemia1241 topic
  13. Childhood Cancer1241 topic
  14. Classification1171 topic
  15. Lymphoma1171 topic
  16. Cancer Genomics1011 topic
  17. Mutational Signatures1011 topic
  18. Diagnosis Criteria701 topic
  19. International Myeloma Working Group701 topic

Where does Claudia Haferlach work?

Claudia Haferlach's main affiliation in the publication record is Munich Leukemia Laboratory (Germany), Germany.

How many publications and citations does Claudia Haferlach have?

OpenAlex counts 1,335 works and 31,951 citations for Claudia Haferlach, an h-index of 85, ranking #381,799 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Claudia Haferlach

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Claudia Haferlach. Posts are plain text and can be reported.